Cargando…
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation
Plasma cell leukemia (PCL) is a rare disease that represents approximately 4% of plasma cell malignant disorders. PCL consists of two variants: primary PCL presents in patients with no previous history of multiple myeloma, while secondary PCL consists of a leukemic transformation in a previously rec...
Autores principales: | Ozasa, Ryotaro, Hotta, Masaaki, Yoshimura, Hideaki, Nakanishi, Takahisa, Tamaki, Takeshi, Fujita, Shinya, Nakamichi, Naoto, Miyaji, Michihiko, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658252/ https://www.ncbi.nlm.nih.gov/pubmed/23754921 http://dx.doi.org/10.2147/IMCRJ.S33293 |
Ejemplares similares
-
Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan
por: Yoshimura, Hideaki, et al.
Publicado: (2017) -
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
por: Nomura, Shosaku, et al.
Publicado: (2018) -
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report
por: FUJITA, YUKIE, et al.
Publicado: (2016) -
Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma
por: Nakaya, Aya, et al.
Publicado: (2016) -
Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia
por: Nakaya, Aya, et al.
Publicado: (2018)